Warren Averett Asset Management, LLC Clearside Biomedical, Inc. Transaction History
Warren Averett Asset Management, LLC
- $7.99 Billion
- Q1 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 18,380 shares of CLSD stock, worth $7,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,380
Previous 21,965
16.32%
Holding current value
$7,535
Previous $21,000
23.81%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLSD
# of Institutions
51Shares Held
11.4MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA2.81MShares$1.15 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$900,9663.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$618,4200.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$327,2360.0% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$324,0520.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $24.7M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...